Individual access request (IAR)
Patients with an unmet medical need often require access to a medicine that is not commercially available in the country where they live. When we receive such a request from a healthcare professional, if we do not already have it in stock, we find a source of the product and ensure we deliver it, in compliance with appropriate regulations, to the relevant medical establishment ready for the patient to receive treatment. The term we use for this service is Individual Access Request.
Aposave access programmes (AAP)
Aposave is a strategic partner to the pharmaceutical and biotech industry. AAPs provide a framework for a partnership where Aposave creates, implements and manages a programme on behalf of a drug manufacturer to provide access to their drug in countries where it is not commercially available. This can be either in the prelaunch or the post launch stage of the product lifecycle. Each programme is designed to meet the specific needs of the manufacturer.
Specialty commercial distribution (SCD)
Aposave has extensive knowledge and experience in managing the distribution of specialty medicines. Higher value, lower volumes of specialty medicines often do not sit well with the traditional distribution model. In addition, we are able to provide ancillary services such as labelling and packaging. Aposave can provide a high touch, specialty distribution service for these medicines, delivering directly to healthcare establishments in a timely and compliant manner.
Clinical trial solutions (CTS)
Aposave has a range of services to support the efficient running of clinical trials. The Abacus Medicine Group holds over 4500 marketing authorisations which gives Aposave unrivalled access to the medicines required to support the running of clinical trials. Aposave has also developed some unique approaches to minimising wastage of products that have expired or are no longer required for a trial.